A detailed history of Ever Source Wealth Advisors, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 25 shares of PCVX stock, worth $2,163. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Previous 26 3.85%
Holding current value
$2,163
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$70.52 - $117.12 $70 - $117
-1 Reduced 3.85%
25 $2,000
Q2 2024

Aug 13, 2024

BUY
$60.06 - $78.77 $420 - $551
7 Added 36.84%
26 $1,000
Q1 2024

Jun 11, 2024

SELL
$59.79 - $81.05 $10,463 - $14,183
-175 Reduced 90.21%
19 $1,000
Q4 2023

Feb 09, 2024

BUY
$45.35 - $63.41 $7,437 - $10,399
164 Added 546.67%
194 $12,000
Q3 2023

Nov 03, 2023

BUY
$46.0 - $53.1 $46 - $53
1 Added 3.45%
30 $1,000
Q2 2023

Aug 04, 2023

BUY
$34.66 - $54.07 $1,005 - $1,568
29 New
29 $1,000

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $5.13B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.